Stay Connected

New Therapeutic Options for Migraine: The Role of Nurse Practitioners in Patient Management

Georgia Nurses Association
3032 Briarcliff Road Northeast
Atlanta, GA 30329

Saturday, March 14, 2020 at 10:00am ET - 11:00am ET
This event has ended.

3032 Briarcliff Road Northeast, Atlanta, GA 30329

Info

Topic

This CME activity, New Therapeutic Options for Migraine: The Role of Nurse Practitioners in Patient Management, will address the integral role of nurse practitioners (NPs) in migraine management, review current evidence in the diagnosis and treatment of migraine, describe the role of CGRP in migraine pathophysiology, and examine the role and placement of newly approved CGRP-targeted therapies.

Speaker(s)

CHRISTINA TREPPENDAHL, FNP-BC, AQH, MHD

Credits Offered

This event offers 1.0 CE credit to attendees.


Additional Information

Research has led to an improved understanding of the pathophysiology of migraine, as well as the subsequent development of therapeutic agents shown to improve the prevention and management of the condition. Elucidating the role of calcitonin gene-related peptide (CGRP) in the development of migraine (in particular chronic migraine) can aid clinicians in improving the management of their patients and optimizing outcomes.

This CME activity, New Therapeutic Options for Migraine: The Role of Nurse Practitioners in Patient Management, will address the integral role of nurse practitioners (NPs) in migraine management, review current evidence in the diagnosis and treatment of migraine, describe the role of CGRP in migraine pathophysiology, and examine the role and placement of newly approved CGRP-targeted therapies.

Learning Objectives:

• Recognize the signs and symptoms of migraine utilizing diagnostic criteria

• Describe the pathophysiology of migraine, including the role of CGRP

• Utilize pharmacologic, nonpharmacologic, and preventive therapies to develop an individualized migraine treatment plan for each patient
• Review clinical-trial data on the efficacy/safety of new and emerging therapeutic agents for the prevention of migraines


This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.


Jointly provided by USF Health and Rockpointe.

For questions, please contact GNA Communications Manager Charlotte Baez-Diaz at charlotte.baez-diaz@georgianurses.org.